| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
HC Wainwright & Co. analyst Yi Chen reiterates Icecure Medical (NASDAQ:ICCM) with a Buy and maintains $3 price target.
Data presentation at highly influential American Society of Breast Surgeons ("ASBrS") Annual Meeting by Dr. Richard Fin...
HC Wainwright & Co. analyst Yi Chen reiterates Icecure Medical (NASDAQ:ICCM) with a Buy and maintains $3 price target.
Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. The com...
Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.32) per share which met the analyst consensus estimate. This is ...
Companies Reporting Before The Bell • Acuity Brands (NYSE:AYI) is projected to report quarterly earnings at $3.25 per share on...
Alliance Global Partners analyst Ben Haynor maintains Icecure Medical (NASDAQ:ICCM) with a Buy and raises the price target f...
